Huntingtin is a protein found in the central nervous system (CNS) that is associated with Huntington's disease, a rare, inherited neurological disorder. The Huntingtin market is a subset of the CNS drugs market, which is focused on developing treatments for neurological disorders. The Huntingtin market is composed of companies that are researching and developing drugs to treat Huntington's disease. These drugs are designed to reduce the production of the mutated Huntingtin protein, which is responsible for the symptoms of the disease. The Huntingtin market is a relatively small market, but it is growing as more companies enter the space. Companies in the Huntingtin market include Ionis Pharmaceuticals, Roche, Novartis, and Sanofi. These companies are researching and developing drugs to treat Huntington's disease, as well as other neurological disorders. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
